5-32710655-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BA1
The NM_001363652.2(NPR3):c.-8G>A variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00682 in 1,501,148 control chromosomes in the GnomAD database, including 621 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).
Frequency
Genomes: 𝑓 0.037 ( 359 hom., cov: 32)
Exomes 𝑓: 0.0034 ( 262 hom. )
Consequence
NPR3
NM_001363652.2 5_prime_UTR
NM_001363652.2 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.52
Genes affected
NPR3 (HGNC:7945): (natriuretic peptide receptor 3) This gene encodes one of three natriuretic peptide receptors. Natriutetic peptides are small peptides which regulate blood volume and pressure, pulmonary hypertension, and cardiac function as well as some metabolic and growth processes. The product of this gene encodes a natriuretic peptide receptor responsible for clearing circulating and extracellular natriuretic peptides through endocytosis of the receptor. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Feb 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -13 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.61).
BP6
Variant 5-32710655-G-A is Benign according to our data. Variant chr5-32710655-G-A is described in ClinVar as [Benign]. Clinvar id is 3044637.Status of the report is no_assertion_criteria_provided, 0 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.128 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NPR3 | NM_001363652.2 | c.-8G>A | 5_prime_UTR_variant | 1/8 | NP_001350581.1 | |||
NPR3 | NM_001204376.2 | c.-8G>A | 5_prime_UTR_variant | 1/8 | NP_001191305.1 | |||
NPR3 | NM_001364460.2 | c.-8G>A | 5_prime_UTR_variant | 1/7 | NP_001351389.1 | |||
NPR3 | NM_001364458.2 | c.50-14043G>A | intron_variant | NP_001351387.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NPR3 | ENST00000506712.1 | n.2G>A | non_coding_transcript_exon_variant | 1/6 | 1 | |||||
NPR3 | ENST00000434067 | c.-8G>A | 5_prime_UTR_variant | 1/8 | 5 | ENSP00000388408.2 | ||||
NPR3 | ENST00000326958 | c.-8G>A | 5_prime_UTR_variant | 1/8 | 2 | ENSP00000318340.2 | ||||
NPR3 | ENST00000509104.5 | c.101-14043G>A | intron_variant | 2 | ENSP00000425325.1 |
Frequencies
GnomAD3 genomes AF: 0.0369 AC: 5605AN: 152080Hom.: 359 Cov.: 32
GnomAD3 genomes
AF:
AC:
5605
AN:
152080
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00709 AC: 814AN: 114874Hom.: 46 AF XY: 0.00568 AC XY: 351AN XY: 61776
GnomAD3 exomes
AF:
AC:
814
AN:
114874
Hom.:
AF XY:
AC XY:
351
AN XY:
61776
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00343 AC: 4633AN: 1348950Hom.: 262 Cov.: 31 AF XY: 0.00297 AC XY: 1961AN XY: 660084
GnomAD4 exome
AF:
AC:
4633
AN:
1348950
Hom.:
Cov.:
31
AF XY:
AC XY:
1961
AN XY:
660084
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0369 AC: 5611AN: 152198Hom.: 359 Cov.: 32 AF XY: 0.0346 AC XY: 2575AN XY: 74434
GnomAD4 genome
AF:
AC:
5611
AN:
152198
Hom.:
Cov.:
32
AF XY:
AC XY:
2575
AN XY:
74434
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
28
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
NPR3-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jul 30, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at